Enkhmaa, Byambaa

Prevalence of the Metabolic Syndrome using the Modified ATP III Definitions for Workers in Japan, Korea and Mongolia

Shiwaku, K., Nogi, A., Kitajima, K., Anuurad, E., Enkhmaa, B., Yamasaki, M., Kim, J., Kim, I., Lee, S., Oyunsuren, T., et al. (2005) · Journal of Occupational Health

Diabetes, Cardiovascular Risks, and LipoproteinsDiet, Metabolism, and Disease

Cited by 117

Prevalence of the metabolic syndrome using the Third Report of the National Cholesterol Educational Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (ATP III) and the modified ATP III definitions for Japanese and Mongolians

Enkhmaa, B., Shiwaku, K., Anuurad, E., Nogi, A., Kitajima, K., Yamasaki, M., Oyunsuren, T., & Yamane, Y. (2005) · Clinica Chimica Acta

Diabetes, Cardiovascular Risks, and LipoproteinsAdipokines, Inflammation, and Metabolic Diseases

Cited by 61

Impact of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors on Lipoprotein(a)

Rivera, F. B., Cha, S. W., Linnaeus Louisse, C., Carado, G. P., Magalong, J. V., Tang, V. A., Enriquez, M. G., Gulati, M., Enkhmaa, B., Pagidipati, N., et al. (2025) · JACC: Advances

Lipoproteins and Cardiovascular HealthLipid metabolism and disorders

Cited by 25

Enigmatic role of lipoprotein(a) in cardiovascular disease.

Anuurad, E., Enkhmaa, B., & Berglund, L. (2010) · Clinical and Translational Science

Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism

Cited by 14